Jeremy's research focus on risk stratification of non-ischaemic cardiomyopathies using cardiac imaging and artificial intelligence. 🖥️
#ecr_isc#research#cardiovascular#congress
Meet Jeremy during the cardiovascular session next Friday! 🫀
Jeremy is a junior cardiologist in Clermont-Ferrand, currently doing a Master 2 in Paris (AP-HP, Lariboisière) and starting his PhD next November.
Valention also co-founded and was co-head of the Young Members Committee of the French-Speaking Society of Transplantation (SFT Juniors) from 2016 to 2020.
#ecr_isc#congress
Valentin defended a MSc in Immunology and a MD in Nephrology at the University of Montpellier Medical School.
His research interest focus on non-invasive biomarkers and tissue-based bulk and spatial transcriptomics in the field of kidney allo- and xenograft rejection.
We are delighted to introduce another speaker, Valentin, during the Cardiovascular related diseases! ✨
Valentin is a transplant nephrologist and PhD student at Paris Transplant Group (Inserm U970, PARCC), that he joined in 2020.
#congress#transplant#cardiocvascular#ecr_isc
Ionoptix provide innovative tools and technologies to study muscle physiology, including high-speed imaging systems,software for data analysis, and contractility analysis equipment. Their products are used worldwide to advance our understanding of muscle function and dysfunction.
Meet more of our sponsors!! ✨
IonOptix is a company specializing in advanced solutions for cardiac and skeletal muscle research🫀
#ecr_isc#congress#cardiac#research
Meet Alexandre Unger at Cardio session!🫀
Alexandre is a young cardiologist from Belgium, currently pursuing a PhD between Paris and Brussels. His research focuses on the risk stratification of cardiovascular diseases through the application of cardiac imaging and data science.
In his studies, Daniel tried to understand the contribution of a specific post-translational modification (O-GlcNAc) to the vascular damage caused by aldosterone and which signalling pathways O-GlcNAc could be modulating to lead to aldosterone-induced vascular damage.
#ECR_ISC
Meet our speakers ! 🔊
We are delighted to welcome Daniel for our Vascular Session ! 👨🏼🔬
Daniel is a Biomedical Scientist and PhD student in Vascular Pharmacology at the University of São Paulo, Brazil.
@orodriguesdani#congress#cardiovascular#research#ecr_isc
Meet our second sponsor POLYGON Therapeutics! 🧬
POLYGON Therapeutics aims to address unmet therapeutic needs through innovative breakthrough approaches🧑🔬
Within its first therapeutic development program EMOTION, POLYGON aspires to transform cardiovascular disease care 🫀
Meet our first sponsor! Clinisciences 🧬
Discover groundbreaking innovations and unlock new possibilities by visiting their stand and discussing with professionals! 🔬✨
See you there!
#clinisciences#conference#ECR_ISC
Happy to announce our 2nd edition of the Early Career Researchers' Congress of the Institut des Sciences Cardiovasculaire!
📆 April 19th
🧑🔬 ECRs include students and researchers at the beginning of their career.
Register and submit your abstract:
sondage.app.u-paris.fr/177461?lang=fr…